Humana Inc. (HUM) Pops 3.47% for February 22

Equities Staff |

One of the S&P 500’s big winners for Monday February 22 was Humana Inc. (HUM) as the company’s stock climbed 3.47% to $171.07 on volume of 770,713 shares.

The stock opened at $166.50 and saw an intraday low of $165.34 and an intraday high of $171.61. All told, the day saw a per-share gain of $5.73. The stock’s average daily volume of 1.1 million and 148.3 million shares outstanding. Humana Inc. now has a 50-day SMA is $169.44 and 200-day SMA is $179.73, and it has a 52-week high of $219.79 and a 52-week low of $155.24.

Humana Inc is a health care company that offers insurance products and health and wellness services. Its segments include Retail, Employer Group and Healthcare Services.

Based out of Louisville, KY, Humana Inc. has 51,700 employees and, after today’s trading, reached a market cap of $25.37 billion. The stock’s P/E Ratio is 19.6. Its P/S ratio is 0.45, P/B ratio is 2.45, and P/FCF ratio is 20.5.

For a complete fundamental analysis analysis of Humana Inc., check out’s Stock Valuation Analysis report for HUM. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Propanc Health Group Corp

Propanc Health Group Corp is an early stage healthcare company. It is engaged in developing new cancer treatments for patients, suffering from pancreatic and colorectal cancer.

Private Markets


Snapchat is the fastest way to share a moment with friends. The mobile app, allows users to not only share photos with friends but also control how long they can…

Cross Campus

With over 500 members and operating 80,000 square feet by summer 2016, Cross Campus is one of the country’s top ten shared, collaborative office or "coworking" operators in the US.…